About ReGenTree
The company was founded with the aim of becoming a global leader in the pharmaceutical industry for ophthalmic disorders.
Learn MorePipeline
ReGenTree is focusing on eye products for dry eye syndrome and for neurotrophic keratopathy with the naturally occurring regenerative protein, Thymosin β4 (Tβ4).
Learn MoreNews & PR
- 2025.03.27 [RegeneRX] Letter to Stockholders-3-27...
- 2025.03.27 HLB테라퓨틱스, 신경영양성각막염 신약 후보물질 임상3상 환자 '추적...
- 2024.12.17 [RegeneRX] Letter to Stockholders 12-1...